ARCHIVES

Agencies Plan Better Reporting Of Adverse Events In Trials.

This article is from The Cancer Letter archive.

Vol. 26 No. 05 | February 4, 2000

Download PDF Visit The Full Archive

Related Articles

Firm Wins Patent For Method, Apparatus For Cryoablation.

December 15, 2000

In Brief: Bruce Chabner, DC director, To Leave NCI Next Spring For Position At Mass General

October 28, 1994

As MD Anderson Targets Eight Cancers, Detailed War Plan Remains Under Wraps

September 21, 2012

Phase III Trial of Alimta, Avastin Combination Fails Endpoint to Improve Overall Survival

September 28, 2012

NCI Contract Awards.

February 18, 2000

Turmoil in Texas: Texas Agency Funded $11 Million Grant Without Peer Review; Official Resigns

November 30, 2012